CIK 0001512762 · Accelerated filer<br>Smaller reporting company
Coherus Oncology, Inc.
Sign in to watch- Ticker
- CHRS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 273615821
- Phone
- (650) 649-3530
- Business address
- C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
- Former names
- Coherus BioSciences, Inc., BioGenerics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-09-16 | Lanfear Dennis M President and CEO | Sale | −2,900 | $31.79 | $92K | 1,341,626 |
| 2016-09-01 | Herman Alan C. Chief Scientific Officer | Sale | −16,999 | $29.99 | $510K | 169,783 |
| 2016-08-08 | Watler Peter K. Chief Technical Officer | Option exercise | +40,000 | $2.08 | $83K | 40,000 |
| 2016-08-08 | Watler Peter K. Chief Technical Officer | Sale | −40,000 | $30.00 | $1.2M | 0 |
| 2016-08-08 | Watler Peter K. Chief Technical Officer | Option exercise | +15,621 | $2.50 | $39K | 15,621 |
| 2016-08-08 | Watler Peter K. Chief Technical Officer | Sale | −15,621 | $30.00 | $469K | 0 |
| 2016-08-08 | Watler Peter K. Chief Technical Officer | Option exercise · Stock Option (right to buy) | −40,000 | 48,503 | ||
| 2016-08-08 | Watler Peter K. Chief Technical Officer | Option exercise · Stock Option (right to buy) | −15,621 | 14,373 | ||
| 2016-08-08 | FMR LLC See Remark 1 | Sale | −475 | $29.89 | $14K | 461,119 |
| 2016-08-08 | FMR LLC See Remark 1 | Sale | −2,100 | $29.89 | $63K | 459,019 |
| 2016-08-08 | FMR LLC See Remark 1 | Sale | −1,100 | $29.92 | $33K | 457,919 |
| 2016-08-08 | FMR LLC See Remark 1 | Sale | −1,349 | $29.84 | $40K | 456,570 |
| 2016-08-08 | FMR LLC See Remark 1 | Sale | −84,976 | $29.86 | $2.5M | 371,594 |
| 2016-08-08 | FMR LLC See Remark 1 | Sale | −10,000 | $29.87 | $299K | 361,594 |
| 2016-08-05 | FMR LLC 10% owner | Sale | −25,000 | $28.78 | $720K | 461,594 |
| 2016-08-04 | FMR LLC 10% owner | Sale | −23,200 | $28.16 | $653K | 486,994 |
| 2016-08-04 | FMR LLC 10% owner | Sale | −200 | $27.97 | $6K | 486,794 |
| 2016-08-04 | FMR LLC 10% owner | Sale | −100 | $27.87 | $3K | 486,694 |
| 2016-08-04 | FMR LLC 10% owner | Sale | −100 | $27.95 | $3K | 486,594 |
| 2016-08-01 | Herman Alan C. Chief Scientific Officer | Sale | −11,333 | $25.54 | $289K | 186,782 |
Page 27 of 39 · 768 trades